UnitedHealth Group's results for Q3 2026 (quarter ended Sep 30, 2026) come from the company's own earnings release, filed with the SEC on 2026-10-13. Everything below is taken from that filing; quotes are copied exactly. Company outlooks are the company's own.
At a glance
| Item | Value |
|---|---|
| Revenue (GAAP) | $112,694 million (−0.4% vs a year earlier) |
| Diluted EPS (GAAP) | $4.56 |
| Adjusted per-share figure (company's non-GAAP measure; FFO/AFFO for REITs) | $4.69 |
| Full-year guidance | Raised |
Guidance
UnitedHealth raised 2026 guidance: diluted EPS of at least $19.50 and adjusted EPS of at least $20.50.
Why this label: 'reported third quarter 2026 results and raised guidance for full year 2026'; now expects adjusted EPS of at least $20.50 (EPS at least $19.50); prior not stated.
| Metric | Period | New | Prior (as stated in the release) |
|---|---|---|---|
| diluted EPS | FY2026 | at least $19.50 | not stated |
| adjusted EPS | FY2026 | at least $20.50 | not stated |
From the release
Revenue: "UnitedHealth Group’s third quarter 2026 revenues were $112.7 billion compared to $113.2 billion in the third quarter 2025."
Earnings per share: "Earnings of $4.56 Per Share and Adjusted Earnings of $4.69 Per Share"
diluted EPS: "Updated Full Year 2026 Earnings Outlook to At Least $19.50 Per Share; Adjusted Earnings of At Least $20.50 Per Share"
adjusted EPS: "The company now expects full year 2026 adjusted net earnings of at least $20.50 per share, incorporating experience through the third quarter 2026."
Key fact: Raised 2026 adjusted EPS outlook to at least $20.50; Q3 medical care ratio 88.4%.
Source
UnitedHealth Group earnings release (SEC filing), accession 0000731766-26-000255, filed 2026-10-13.
Part of the Q3 2026 Guidance Tracker. Educational only, not advice. Free weekly recap every Sunday: yieldterminalpro.com/newsletter.